Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Reprogramming fibroblast into human iBlastoids

Abstract

The study of early human embryogenesis has relied on the use of blastocysts donated to research or simple stem cell culture systems such as pluripotent and trophoblast stem cells, which have been seminal in shedding light on many key developmental processes. However, simple culture systems lack the necessary complexity to adequately model the spatiotemporal, cellular and molecular dynamics occurring during the early phases of embryonic development. As such, an in vitro model of the human blastocyst is advantageous in many aspects to decipher human embryogenesis. Here we describe a step-by-step protocol for the generation of induced blastoids (iBlastoids), an in vitro integrated model of the human blastocyst derived via somatic reprogramming. This protocol details the workflow for reprogramming of human dermal fibroblasts and subsequent generation of iBlastoids using the reprogramming intermediates, which together takes ~27 days (21 days for reprogramming and 6 days for iBlastoid generation). We also discuss several characterization/functional assays that can be used on the iBlastoids. We believe that a person trained in cell culture with ~1 year of experience with human somatic cell and reprogramming/cell differentiation assays would be able to perform this protocol. In short, the iBlastoids present an alternative tool as a model to the blastocyst to facilitate the scientific community in the exploration of early human development.

Key points

  • This protocol describes the generation of induced blastoids, an in vitro integrated model of the human blastocyst derived via somatic reprogramming. This model overcomes restrictions associated with the use of human blastocysts in embryology research.

  • Compared with other blastoid models, which are generated from established stem cell lines, this protocol leverages on the cellular plasticity in the reprogramming cells, allowing direct generation of blastocyst-like structures from fibroblast.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Reprogramming of fibroblasts up to day 21 of reprogramming.
Fig. 2: Cellular heterogeneity in day 21 reprogramming cells.
Fig. 3: iBlastoid formation in AggreWell TM400.
Fig. 4: Morphological assessment and lineage marker expression of iBlastoids.
Fig. 5: Stem cell lines derivation from iBlastoids.
Fig. 6: In vitro attachment assay using iBlastoids.

Similar content being viewed by others

Data availability

The main data discussed in this protocol were generated as part of the studies published in the supporting primary research paper18.

References

  1. Fu, J., Warmflash, A. & Lutolf, M. P. Stem-cell-based embryo models for fundamental research and translation. Nat. Mater. 20, 132–144 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Rossant, J. & Tam, P. P. L. Opportunities and challenges with stem cell-based embryo models. Stem Cell Rep. 16, 1031–1038 (2021).

    Article  Google Scholar 

  3. Posfai, E., Lanner, F., Mulas, C. & Leitch, H. G. All models are wrong, but some are useful: establishing standards for stem cell-based embryo models. Stem Cell Rep. 16, 1117–1141 (2021).

    Article  CAS  Google Scholar 

  4. Rivron, N. C. et al. Blastocyst-like structures generated solely from stem cells. Nature 557, 106–111 (2018).

    Article  CAS  PubMed  Google Scholar 

  5. Sozen, B. et al. Self-organization of mouse stem cells into an extended potential blastoid. Dev. Cell 51, 698–712.e8 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Li, R. et al. Generation of blastocyst-like structures from mouse embryonic and adult cell cultures. Cell 179, 687–702.e18 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Harrison, S. E., Sozen, B., Christodoulou, N., Kyprianou, C. & Zernicka-Goetz, M. Assembly of embryonic and extraembryonic stem cells to mimic embryogenesis in vitro. Science 356, eaal1810 (2017).

    Article  PubMed  Google Scholar 

  8. Zhang, S. et al. Implantation initiation of self-assembled embryo-like structures generated using three types of mouse blastocyst-derived stem cells. Nat. Commun. 10, 496 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sozen, B. et al. Self-assembly of embryonic and two extra-embryonic stem cell types into gastrulating embryo-like structures. Nat. Cell Biol. 20, 979–989 (2018).

    Article  CAS  PubMed  Google Scholar 

  10. Amadei, G. et al. Inducible stem cell-derived embryos capture mouse morphogenetic events in vitro. Dev. Cell 56, 366–382.e9 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Xu, Y. et al. Derivation of totipotent-like stem cells with blastocyst-like structure forming potential. Cell Res 32, 513–529 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shen, H. et al. Mouse totipotent stem cells captured and maintained through spliceosomal repression. Cell 184, 2843–2859.e20 (2021).

    Article  CAS  PubMed  Google Scholar 

  13. Hu, Y. et al. Induction of mouse totipotent stem cells by a defined chemical cocktail. Nature 617, 792–797 (2022).

    Article  PubMed  Google Scholar 

  14. Amadei, G. et al. Embryo model completes gastrulation to neurulation and organogenesis. Nature 610, 143–153 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tarazi, S. et al. Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs. Cell 185, 3290–3306.e25 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Liu, X. et al. Reprogramming roadmap reveals route to human induced trophoblast stem cells. Nature 586, 101–107 (2020).

    Article  CAS  PubMed  Google Scholar 

  17. Tan, J. P., Liu, X. & Polo, J. M. Establishment of human induced trophoblast stem cells via reprogramming of fibroblasts. Nat. Protoc. 17, 2739–2759 (2022).

    Article  CAS  PubMed  Google Scholar 

  18. Liu, X. et al. Modelling human blastocysts by reprogramming fibroblasts into iBlastoids. Nature 591, 627–632 (2021).

    Article  CAS  PubMed  Google Scholar 

  19. Yu, L. et al. Blastocyst-like structures generated from human pluripotent stem cells. Nature 591, 620–626 (2021).

    Article  CAS  PubMed  Google Scholar 

  20. Kagawa, H. et al. Human blastoids model blastocyst development and implantation. Nature 601, 600–605 (2022).

    Article  CAS  PubMed  Google Scholar 

  21. Yanagida, A. et al. Naive stem cell blastocyst model captures human embryo lineage segregation. Cell Stem Cell 28, 1016–1022.e4 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Io, S. et al. Capturing human trophoblast development with naive pluripotent stem cells in vitro. Cell Stem Cell 28, 1023–1039.e13 (2021).

    Article  CAS  PubMed  Google Scholar 

  23. Guo, G. et al. Human naive epiblast cells possess unrestricted lineage potential. Cell Stem Cell 28, 1040–1056.e6 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Fan, Y. et al. Generation of human blastocyst-like structures from pluripotent stem cells. Cell Discov. 7, 81 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sozen, B. et al. Reconstructing aspects of human embryogenesis with pluripotent stem cells. Nat. Commun. 12, 5550 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mazid, M. A. et al. Rolling back human pluripotent stem cells to an eight-cell embryo-like stage. Nature 605, 315–324 (2022).

    Article  CAS  PubMed  Google Scholar 

  27. Yu, X. et al. Recapitulating early human development with 8C-like cells. Cell Rep. 39, 110994 (2022).

    Article  CAS  PubMed  Google Scholar 

  28. Taubenschmid-Stowers, J. et al. 8C-like cells capture the human zygotic genome activation program in vitro. Cell Stem Cell 29, 449–459.e6 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yu, L. et al. Large-scale production of human blastoids amenable to modeling blastocyst development and maternal-fetal cross talk. Cell Stem Cell 30, 1246–1261.e9 (2023).

    Article  CAS  PubMed  Google Scholar 

  30. Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618–630 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Clark, A. T. et al. Human embryo research, stem cell-derived embryo models and in vitro gametogenesis: considerations leading to the revised ISSCR guidelines. Stem Cell Rep. 16, 1416–1424 (2021).

    Article  Google Scholar 

  33. Lovell-Badge, R. et al. ISSCR guidelines for stem cell research and clinical translation: the 2021 update. Stem Cell Rep. 16, 1398–1408 (2021).

    Article  Google Scholar 

  34. Shahbazi, M. N. et al. Self-organization of the human embryo in the absence of maternal tissues. Nat. Cell Biol. 18, 700–708 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Deglincerti, A. et al. Self-organization of the in vitro attached human embryo. Nature 533, 251–254 (2016).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the use of the services and facilities of Monash Micro Imaging at Monash University. This work was supported by the National Health and Medical Research Council project grants APP1104560 and APP2004627 as well as a Synergy grant 2019251 to J.M.P. X.L. was supported by Westlake Education Foundation. J.P.T. was supported by a Monash International Tuition Scholarship, Research Training Program Scholarship and Carmela and Carmelo Ridolfo Prize in Stem Cell Research. J.M.P. was supported by an Australian Research Council Future Fellowship. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The South Australian immunoGENomics Cancer Institute received grant funding from the Australian Government.

Author information

Authors and Affiliations

Authors

Contributions

J.P.T. and X.L. drafted the protocol. J.P.T., X.L. and J.M.P. wrote the protocol. Most experiments presented in this protocol were performed by J.P.T. with supervision from X.L. and J.M.P.

Corresponding authors

Correspondence to Xiaodong Liu or Jose M. Polo.

Ethics declarations

Competing interests

J.P.T, X.L. and J.M.P. are co-inventors on two Patent Cooperation Treaty (PCT) patent applications (application numbers PCT/AU2021/051401 and PCT/AU2021/051402) filed by Monash University related to work on derivation of human iBlastoids and derivatives. J.M.P. is a co-inventor on a patent (WO/2017/106932) and is a co-founder and shareholder of Mogrify Ltd., a cell therapy company. X.L is a co-founder of iCamuno Biotherapeutics Ltd. The other authors declare no competing interests.

Peer review

Peer review information

Nature Protocols thanks Yang Yu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Related links

Key reference using this protocol

Liu, X. et al. Nature 591, 627–632 (2021): https://doi.org/10.1038/s41586-021-03372-y

Key data used in this protocol

Liu, X. et al. Nature 586, 101–107 (2020): https://doi.org/10.1038/s41586-020-2734-6

Extended data

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, J.P., Liu, X. & Polo, J.M. Reprogramming fibroblast into human iBlastoids. Nat Protoc (2024). https://doi.org/10.1038/s41596-024-00984-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41596-024-00984-2

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing